Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
UTHR
|
Martine A Rothblatt
Chairperson & CEO |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 98.4% |
$2,093,520
$261.69 p/Share
|
Jan 31
2023 |
FTCI
|
Arc Family Trust
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 0.16% |
$68,000
$2.72 p/Share
|
Jan 31
2023 |
MS
|
Daniel A Simkowitz
Co-President |
SELL
Open market or private sale
|
Direct | 8,077 Reduced 2.5% |
$779,753
$96.54 p/Share
|
Jan 31
2023 |
UMBF
|
J Mariner Kemper
Chairman and CEO |
SELL
Open market or private sale
|
Indirect | 4,252 Reduced 0.0% |
$377,152
$88.7 p/Share
|
Jan 31
2023 |
TER
|
Charles Jeffrey Gray
VP, General Counsel, Secretary |
SELL
Open market or private sale
|
Direct | 686 Reduced 2.86% |
$68,600
$100.0 p/Share
|
Jan 31
2023 |
UMBF
|
J Mariner Kemper
Chairman and CEO |
SELL
Open market or private sale
|
Indirect | 1,792 Reduced 0.0% |
$158,090
$88.22 p/Share
|
Jan 31
2023 |
UMBF
|
J Mariner Kemper
Chairman and CEO |
SELL
Open market or private sale
|
Indirect | 4,956 Reduced 0.0% |
$441,678
$89.12 p/Share
|
Jan 31
2023 |
AROW
|
Colin L Read
Director |
SELL
Open market or private sale
|
Direct | 300 Reduced 2.75% |
$9,900
$33.0 p/Share
|
Jan 31
2023 |
MOG-B
|
Donald R Fishback
Director |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$190,200
$95.1 p/Share
|
Jan 31
2023 |
ACT
|
Genworth Holdings, Inc. |
SELL
Open market or private sale
|
Direct | 207,007 Reduced 0.16% |
$4,995,078
$24.13 p/Share
|
Jan 31
2023 |
SPPI
|
Thomas J Riga
Director |
SELL
Open market or private sale
|
Direct | 107,424 Reduced 5.35% |
$70,899
$0.66 p/Share
|
Jan 31
2023 |
SPPI
|
Keith M Mc Gahan
Officer |
SELL
Open market or private sale
|
Direct | 41,014 Reduced 5.97% |
$25,428
$0.62 p/Share
|
Jan 31
2023 |
ZION
|
Terry Alan Shirey
Executive Vice President |
SELL
Open market or private sale
|
Direct | 2,248 Reduced 10.47% |
$118,784
$52.84 p/Share
|
Jan 31
2023 |
ZION
|
Alan M Forney
Exec VP & Division CEO |
SELL
Open market or private sale
|
Direct | 4,307 Reduced 19.3% |
$228,357
$53.02 p/Share
|
Jan 31
2023 |
BFI
|
John Rosatti Revocable Trust
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.0% |
$8,650
$1.73 p/Share
|
Jan 31
2023 |
XPEL
|
Richard K. Crumly
Director |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.0% |
$765,400
$76.54 p/Share
|
Jan 31
2023 |
BSVN
|
Thomas L Travis
President & CEO |
SELL
Open market or private sale
|
Direct | 6,500 Reduced 1.99% |
$175,890
$27.06 p/Share
|
Jan 31
2023 |
BKR
|
Maria C Borras
Chief Growth & Experience Ofcr |
SELL
Open market or private sale
|
Direct | 9,811 Reduced 14.16% |
$303,454
$30.93 p/Share
|
Jan 31
2023 |
TMHC
|
Sheryl Palmer
Chairman, President and CEO |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 25.25% |
$3,513,000
$35.13 p/Share
|
Jan 31
2023 |
HRI
|
Icahn Carl C
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 40,174 Reduced 0.0% |
$6,181,975
$153.88 p/Share
|
Jan 31
2023 |
TMHC
|
William H Lyon
Director |
SELL
Open market or private sale
|
Indirect | 3,000 Reduced 0.0% |
$106,500
$35.5 p/Share
|
Jan 31
2023 |
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 725 Reduced 0.0% |
$120,661
$166.43 p/Share
|
Jan 31
2023 |
MEG
|
Richard E Perlman |
SELL
Open market or private sale
|
Direct | 43,071 Reduced 5.31% |
$2,309,467
$53.62 p/Share
|
Jan 31
2023 |
NFLX
|
Jay C Hoag
Director |
SELL
Open market or private sale
|
Direct | 3,698 Reduced 100.0% |
$1,305,172
$352.94 p/Share
|
Jan 31
2023 |
OSIS
|
Deepak Chopra
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 3.77% |
$1,857,800
$92.89 p/Share
|
Jan 31
2023 |
MSBI
|
Jeffrey S. Mefford
President |
SELL
Open market or private sale
|
Direct | 1,600 Reduced 4.93% |
$40,368
$25.23 p/Share
|
Jan 31
2023 |
BZFD
|
Comcast Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 2,138,012 Reduced 0.0% |
$5,387,790
$2.52 p/Share
|
Jan 31
2023 |
RGP
|
Anthony Cherbak
Director |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 24.68% |
$254,100
$16.94 p/Share
|
Jan 31
2023 |
SPSC
|
James J. Frome
President and COO |
SELL
Open market or private sale
|
Direct | 5,450 Reduced 13.35% |
$736,349
$135.11 p/Share
|
Jan 31
2023 |
FCFS
|
Douglas Richard Rippel
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 20,019 Reduced 0.0% |
$1,834,941
$91.66 p/Share
|
Jan 31
2023 |
ACTD
|
Arc Light Ctc Holdings Ii, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 14,700 Reduced 0.17% |
$107,604
$7.32 p/Share
|
Jan 31
2023 |
AXGN
|
Peter J Mariani
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 14,320 Reduced 20.49% |
$136,756
$9.55 p/Share
|
Jan 31
2023 |
SPSC
|
Archie C. Black
Director |
SELL
Open market or private sale
|
Direct | 12,505 Reduced 11.06% |
$1,685,674
$134.8 p/Share
|
Jan 31
2023 |
SPSC
|
Archie C. Black
Director |
SELL
Open market or private sale
|
Direct | 4,251 Reduced 4.23% |
$577,710
$135.9 p/Share
|
Jan 31
2023 |
CPK
|
John R Schimkaitis |
SELL
Open market or private sale
|
Direct | 4,629 Reduced 5.47% |
$578,995
$125.08 p/Share
|
Jan 31
2023 |
VYGR
|
Third Rock Ventures Iii, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 185,000 Reduced 3.7% |
$1,711,250
$9.25 p/Share
|
Jan 31
2023 |
XMTR
|
James M Rallo
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 34.51% |
$343,900
$34.39 p/Share
|
Jan 31
2023 |
KDNY
|
Eric Dobmeier
President, CEO |
SELL
Open market or private sale
|
Direct | 7,688 Reduced 2.59% |
$189,739
$24.68 p/Share
|
Jan 31
2023 |
ORGN
|
Boon Sim
Director |
SELL
Open market or private sale
|
Direct | 64,300 Reduced 1.26% |
$389,015
$6.05 p/Share
|
Jan 31
2023 |
VIR
|
Svf Endurance (Cayman) LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 73,883 Reduced 0.0% |
$2,156,644
$29.19 p/Share
|
Jan 31
2023 |
LEVI
|
Lisa Stirling
Global Controller |
SELL
Open market or private sale
|
Direct | 5,017 Reduced 14.98% |
$90,506
$18.04 p/Share
|
Jan 31
2023 |
PLRX
|
Bernard Coulie
President and CEO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 5.88% |
$523,800
$34.92 p/Share
|
Jan 31
2023 |
NTRA
|
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 35,000 Reduced 33.66% |
$1,481,550
$42.33 p/Share
|
Jan 31
2023 |
AA
|
Harden Sonya Elam
EVP & Chief Ext. Aff. Officer |
SELL
Open market or private sale
|
Direct | 4,514 Reduced 13.3% |
$234,141
$51.87 p/Share
|
Jan 31
2023 |
FULT
|
George W Hodges |
SELL
Open market or private sale
|
Indirect | 6,799 Reduced 0.0% |
$112,659
$16.57 p/Share
|
Jan 31
2023 |
NATI
|
Scott Arthur Rust
Executive Vice President |
SELL
Open market or private sale
|
Direct | 2,094 Reduced 3.66% |
$113,599
$54.25 p/Share
|
Jan 31
2023 |
PFS
|
Christopher P Martin
Executive Chairman |
SELL
Open market or private sale
|
Direct | 51,881 Reduced 8.84% |
$1,211,421
$23.35 p/Share
|
Jan 31
2023 |
URGN
|
Jason Drew Smith
General Counsel |
SELL
Open market or private sale
|
Direct | 1,636 Reduced 10.55% |
$16,556
$10.12 p/Share
|
Jan 31
2023 |
URGN
|
Mark Schoenberg
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 1,900 Reduced 1.26% |
$19,228
$10.12 p/Share
|
Jan 31
2023 |
NATI
|
Eric Howard Starkloff
President & CEO |
SELL
Open market or private sale
|
Direct | 35,896 Reduced 9.66% |
$1,947,358
$54.25 p/Share
|
Jan 31
2023 |